Please login to view this media

- Talk
- 23/09/2021
- UK
Biological Injectables for OA; What, When and Why? Close
Description
In this section of a meeting, Fares Haddad concludes his remarks, signaling the end of his segment. Mark Bowditch then takes the floor to express gratitude towards the participants and attendees. He outlines the efforts of the BOA to craft a balanced information and education statement aimed at assisting both members and patients, highlighting their collaboration with Versus Arthritis. Bowditch indicates that the statement will be released soon. He wraps up by thanking all speakers, chairs, and attendees for their participation in the session, hoping that it was both informative and engaging. The session ends with applause, indicating a positive reception.
DOI: 10.1302/3114-221770